Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 459
Immune Disorders Drugs 196
Cardiovascular Drugs 161
Drug Discovery 148
Infectious Diseases Drugs 132
Biopharmaceuticals 127
Endocrine and Metabolic Disorders Drugs 113
Clinical Trials 107
Central Nervous System Drugs 106
Musculoskeletal Disorders Drugs 97
Pharmaceuticals 95
Leukemia Drugs 82
Hematological Drugs 80
Liver and Kidney Disorders Drugs 76
Lymphoma Drugs 62
Dermatological Drugs 59
Diabetes Drugs 57
Skin Cancer Drugs 48
Brain Cancer Drugs 46
Respiratory Drugs 45
Mental Disorders Drugs 43
Lung Cancer Drugs 39
Gastrointestinal Drugs 38
Drug Delivery 36
Pharmaceutical Intermediates 35
Immunosuppressive Drugs 33
Pharmaceutical Manufacturing 31
Infusions and Injectables 30
Liver Cancer Drugs 29
Analgesics 27
Antibiotics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 21
Pancreatic Cancer Drugs 19
HIV/AIDS Drugs 19
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Colon Cancer Drugs 17
Schizophrenia Drugs 17
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Ovarian Cancer Drugs 15
Thyroid Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Psoriasis Drugs 12
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Vaccines 8
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



279 reviews

2,424 Results (Page 49 of 122)
- Relevance
  Sort by

B-Cell Lymphoma Treatment - Global Strategic Business Report

 Report
August 2025
392 Pages
Global

From

€5210EUR$5,850USD£4,507GBP

Hodgkins Lymphoma Treatment - Global Strategic Business Report

 Report
August 2025
127 Pages
Global

From

€5210EUR$5,850USD£4,507GBP

HPV Associated Disorders Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3999EUR$4,490USD£3,459GBP

Cervical Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€4008EUR$4,500USD£3,467GBP

Non-Hodgkin Lymphoma Therapeutics - Global Strategic Business Report

 Report
August 2025
192 Pages
Global

From

€5210EUR$5,850USD£4,507GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics - Global Strategic Business Report

 Report
August 2025
273 Pages
Global

From

€5210EUR$5,850USD£4,507GBP

Human Papillomavirus (HPV) Associated Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€4008EUR$4,500USD£3,467GBP

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
October 2022
292 Pages
Global

From

€2227EUR$2,500USD£1,926GBP

Mycosis Fungoides Therapeutics - Global Strategic Business Report

 Report
August 2025
182 Pages
Global

From

€5210EUR$5,850USD£4,507GBP

Generic Pharmaceuticals Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3999EUR$4,490USD£3,459GBP

Hypereosinophilic Syndrome Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
78 Pages
Global

From

€3500EUR$4,210USD£3,133GBP

Hydroxycarbamide Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
May 2023
99 Pages
Global

From

€3500EUR$4,210USD£3,133GBP

Cancer Vaccines Market - Forecasts from 2024 to 2029

 Report
August 2024
135 Pages
Global

From

€2815EUR$3,160USD£2,434GBP

€3518EUR$3,950USD£3,043GBP

Prostate Cancer Therapeutics Market by Therapeutic Mechanism (Chemotherapy, Hormone Therapy, Immunotherapy), Therapy Line (First Line, Second Line, Third Line And Beyond), Formulation, Distribution Channel, End User - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3158EUR$3,545USD£2,731GBP

€3508EUR$3,939USD£3,035GBP

Lenalidomide Market by Type and by Application, by End-User, and By Region

 Report
March 2024
200 Pages
Global

From

€3696EUR$4,150USD£3,197GBP

Cervical Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€2227EUR$2,500USD£1,926GBP

Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region

 Report
March 2024
200 Pages
Global

From

€3696EUR$4,150USD£3,197GBP

Prostate Health Market by Product Type (Diagnostic Kits, Drugs, Imaging Systems), Indication (Benign Prostatic Hyperplasia, Prostate Cancer, Prostatitis), End User, Distribution Channel, Technology Type - Global Forecast 2025-2030

 Report
August 2025
199 Pages
Global

From

€3158EUR$3,545USD£2,731GBP

€3508EUR$3,939USD£3,035GBP

Advanced Cervical Cancer - Pipeline Insight, 2025

 Drug Pipelines
April 2025
160 Pages
Global

From

€2227EUR$2,500USD£1,926GBP

Immunomodulators Market by Product Type (Cytokines And Interferons, Monoclonal Antibodies, Small Molecules), Route Of Administration (Intravenous, Oral, Subcutaneous), Indication, Distribution Channel, End User - Global Forecast 2025-2030

 Report
August 2025
195 Pages
Global

From

€3158EUR$3,545USD£2,731GBP

€3508EUR$3,939USD£3,035GBP

2,424 Results (Page 49 of 122)
- 1
- 47
- 48
- 49
- 50
- 51

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.